We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Major points
- General scientific and ethical rationale for clinical research
- Pediatric research rationale
- American Academy of Pediatrics guidelines (1995)
- Post natal ontogeny affects food and drug absorption: Premature infants and neonates
- Post natal ontogeny affects food and drug absorption across additional pediatric age groups
- Post natal ontogeny affects food and drug distribution: Premature infants and neonates
- Post natal ontogeny affects food and drug distribution across additional pediatric age groups
- Post natal ontogeny affects food and drug metabolism: Premature infants and neonates
- Post natal ontogeny affects food and drug metabolism across additional pediatric age groups
- Post natal ontogeny affects food and drug renal excretion: Premature infants and neonates
- Post natal ontogeny affects food and drug renal excretion across additional pediatric age groups
- Post natal ontogeny affects food and drug hepatic elimination: Premature infants and neonates
- Post natal ontogeny affects food and drug hepatic elimination across additional pediatric age groups
- ADME summary
- Post natal ontogeny: Additional dynamics - surface area to volume ratio and skin & BBB permeability
- Post natal ontogeny: Additional dynamics - immune system development and neurohumoral regulation
- Post natal ontogeny: Additional dynamics - more components (1)
- Post natal ontogeny: Additional dynamics - more components (2)
- Post natal ontogeny medicinal product dosing implications
- Dosing approaches
- Body surface and weight-based dosing
- Age-based dosing: Approximations that require careful monitoring
- General pediatric dosing considerations
- Dosage forms
- Financial disclosures
Topics Covered
- Pediatric research rationale
- American Academy of Pediatrics guidelines (1995)
- ADME summary
- Post natal ontogeny: Additional dynamics
- Post natal ontogeny medicinal product dosing implications
- Dosing approaches
- Body surface and weight-based dosing
- Age-based dosing: Approximations that require careful monitoring
- General pediatric dosing considerations
- Dosage forms
Talk Citation
Hirschfeld, S. (2026, May 28). Pediatric research: technical & logistical considerations - post natal ontogeny [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 29, 2026, from https://doi.org/10.69645/PNFF9116.Export Citation (RIS)
Publication History
- Published on May 28, 2026
Financial Disclosures
- There are no commercial/financial matters to disclose.
Pediatric research: technical & logistical considerations - post natal ontogeny
Published on May 28, 2026
21 min
A selection of talks on Methods
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, this is Prof.
Steven Hirschfeld of
the Uniformed Services University
of the Health Sciences,
and I will be discussing
pediatric research, technical,
and logistical considerations
in a three-part presentation.
This is Part 1 on
postnatal ontogeny.
0:21
The major points across all
three of the
presentations is that
postnatal human
ontogeny is dynamic
and much more than size changes.
Diseases of children are
different at different
ages or manifest
differently than
diseases seen in adults,
and many diseases
are relatively rare,
resulting in design
considerations.
Extrapolation of adult data or
other data to pediatric data
can be useful in the
right circumstances,
and we will discuss how
to apply extrapolation.
Medicinal product
regulatory programs
around the world vary.
The European Union and
the United States of America
have the most robust.
But the whole process
is coordinated by
the International Conference
on Harmonization.
Finally, pediatric
programs require planning,
consultation, and collaboration
with a properly trained
staff and infrastructure.
1:25
The general scientific
and ethical rationale
for clinical research to
evaluate an intervention
is that the intervention
is provided
in the context of a protocol,
the intervention is under
evaluation with equipoise,
participation is voluntary
with documented permission,
and we've discussed in an earlier
talk about the variations
on permission regarding the
participation of children,
the data will be pooled and
analyzed systematically,
the results will
be disseminated,
and a clinical trial process
has greater stringency
and oversight than standard
healthcare delivery.
Specific rationale
for undertaking